Becker's Healthcare July 31, 2023
As demand for GLP-1s such as Ozempic and Wegovy continues to surge, payers and self-insured employers are dropping coverage for the weight loss medications left and right.
According to new data from weight management platform Found, 69 percent of its more than 200,000 patients did not have insurance coverage as of June for GLP-1s for anti-obesity or diabetes, compared to 36 percent with no coverage at the end of 2022.
“Demand has been accelerated through things like TikTok and advertisements around these medications, so a lot more prescriptions are being written,” Found CEO Sarah Jones Simmer told Becker’s. “In reaction, payers are putting more pressure on their PBMs to introduce prior authorization or create more hurdles to getting access...
Today's Sponsors
Today's Sponsor